182 related articles for article (PubMed ID: 28811897)
1. Impact of
Akazawa Y; Higashiyama M; Nishino K; Uchida J; Kumagai T; Inoue T; Fujiwara A; Tokunaga T; Okami J; Imamura F; Kodama K; Kobayashi H
Mol Clin Oncol; 2017 Sep; 7(3):327-335. PubMed ID: 28811897
[TBL] [Abstract][Full Text] [Related]
2. Collagen gel droplet-embedded culture drug sensitivity test for adjuvant chemotherapy after complete resection of non-small-cell lung cancer.
Inoue M; Maeda H; Takeuchi Y; Fukuhara K; Shintani Y; Funakoshi Y; Funaki S; Nojiri T; Kusu T; Kusumoto H; Kimura T; Okumura M;
Surg Today; 2018 Apr; 48(4):380-387. PubMed ID: 28993901
[TBL] [Abstract][Full Text] [Related]
3. Prediction of chemotherapeutic effect on postoperative recurrence by in vitro anticancer drug sensitivity testing in non-small cell lung cancer patients.
Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Imamura F; Minamikawa K; Takano T; Kobayashi H
Lung Cancer; 2010 Jun; 68(3):472-7. PubMed ID: 19660825
[TBL] [Abstract][Full Text] [Related]
4. Role of Collagen Gel Droplet-Embedded Culture-Drug Sensitivity Testing (CD-DST) for Assessing the Sensitivity of Gastric Cancer to Chemotherapy Drugs Combined with Other Cancer Therapeutic Drugs.
Makino H; Nomura S; Kogo H; Wada N; Hayashi M; Yoshida H
J Nippon Med Sch; 2022 Aug; 89(4):412-421. PubMed ID: 35400719
[TBL] [Abstract][Full Text] [Related]
5. In vitro-chemosensitivity test using the collagen gel droplet embedded culture drug test (CD-DST) for malignant pleural mesothelioma: possibility of clinical application.
Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takami K; Morinaga K; Takano T; Kobayashi H
Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):355-62. PubMed ID: 19131921
[TBL] [Abstract][Full Text] [Related]
6. Differences in chemosensitivity between primary and paired metastatic lung cancer tissues: In vitro analysis based on the collagen gel droplet embedded culture drug test (CD-DST).
Higashiyama M; Okami J; Maeda J; Tokunaga T; Fujiwara A; Kodama K; Imamura F; Kobayashi H
J Thorac Dis; 2012 Feb; 4(1):40-7. PubMed ID: 22295166
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST).
Kawamura M; Gika M; Abiko T; Inoue Y; Oyama T; Izumi Y; Kobayashi H; Kobayashi K
Cancer Chemother Pharmacol; 2007 Mar; 59(4):507-13. PubMed ID: 16896928
[TBL] [Abstract][Full Text] [Related]
8. Collagen gel droplet-embedded culture-drug sensitivity test and Ki67 expression in estrogen receptor-positive and HER2-negative breast cancer.
Tozuka K; Horiguchi J; Takata D; Rokutanda N; Nagaoka R; Tokiniwa H; Kikuchi M; Satou A; Takei H; Takeyoshi I
Mol Clin Oncol; 2013 Jan; 1(1):93-99. PubMed ID: 24649129
[TBL] [Abstract][Full Text] [Related]
9. Collagen gel droplet-embedded culture drug sensitivity test (CD-DST) predicts the effect of adjuvant chemotherapy on pancreatic cancer.
Ariake K; Motoi F; Mizuma M; Ohtsuka H; Hayashi H; Nakagawa K; Hata T; Mitachi K; Naitoh T; Kamei T; Unno M
Surg Today; 2019 Dec; 49(12):1035-1043. PubMed ID: 31267224
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: relation of the in vitro chemosensitive test to clinical response.
Higashiyama M; Kodama K; Yokouchi H; Takami K; Nakagawa H; Imamura F; Minamigawa K; Kobayashi H
Oncol Rep; 2001; 8(2):279-83. PubMed ID: 11182040
[TBL] [Abstract][Full Text] [Related]
11. A Retrospective Study of Stage I to IIIa Lung Adenocarcinoma After Resection: What Is the Optimal Adjuvant Modality for Patients With an EGFR Mutation?
Lv C; An C; Feng Q; Ma Y; Li S; Wang J; Zhang J; Wang X; Yan S; Fang J; Wang Y; Tan F; Yang Y
Clin Lung Cancer; 2015 Nov; 16(6):e173-81. PubMed ID: 25958850
[TBL] [Abstract][Full Text] [Related]
12. Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial.
Yue D; Xu S; Wang Q; Li X; Shen Y; Zhao H; Chen C; Mao W; Liu W; Liu J; Zhang L; Ma H; Li Q; Yang Y; Liu Y; Chen H; Wang C
Lancet Respir Med; 2018 Nov; 6(11):863-873. PubMed ID: 30150014
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.
Wakelee HA; Dahlberg SE; Keller SM; Tester WJ; Gandara DR; Graziano SL; Adjei AA; Leighl NB; Aisner SC; Rothman JM; Patel JD; Sborov MD; McDermott SR; Perez-Soler R; Traynor AM; Butts C; Evans T; Shafqat A; Chapman AE; Kasbari SS; Horn L; Ramalingam SS; Schiller JH;
Lancet Oncol; 2017 Dec; 18(12):1610-1623. PubMed ID: 29129443
[TBL] [Abstract][Full Text] [Related]
14. Clinical predictive value of
Mekata E; Sonoda H; Shimizu T; Tatsuta T; Yamaguchi T; Endo Y; Tani T
Mol Clin Oncol; 2013 Jul; 1(4):763-767. PubMed ID: 24649243
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.
Felip E; Altorki N; Zhou C; Csőszi T; Vynnychenko I; Goloborodko O; Luft A; Akopov A; Martinez-Marti A; Kenmotsu H; Chen YM; Chella A; Sugawara S; Voong D; Wu F; Yi J; Deng Y; McCleland M; Bennett E; Gitlitz B; Wakelee H;
Lancet; 2021 Oct; 398(10308):1344-1357. PubMed ID: 34555333
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
17. Successful management of a patient with stage IIIA non-small cell lung cancer using sensitivity-based induction chemotherapy--report of a case.
Gika M; Takeuchi K; Takanami I
Gan To Kagaku Ryoho; 2004 Nov; 31(12):2055-8. PubMed ID: 15570940
[TBL] [Abstract][Full Text] [Related]
18. Exploratory phase II trial in a multicenter setting to evaluate the clinical value of a chemosensitivity test in patients with gastric cancer (JACCRO-GC 04, Kubota memorial trial).
Tanigawa N; Yamaue H; Ohyama S; Sakuramoto S; Inada T; Kodera Y; Kitagawa Y; Omura K; Terashima M; Sakata Y; Nashimoto A; Yamaguchi T; Chin K; Nomura E; Lee SW; Takeuchi M; Fujii M; Nakajima T
Gastric Cancer; 2016 Apr; 19(2):350-360. PubMed ID: 26385385
[TBL] [Abstract][Full Text] [Related]
19. Stratified phase II trial to establish the usefulness of the collagen gel droplet embedded culture-drug sensitivity test (CD-DST) for advanced gastric cancer.
Naitoh H; Yamamoto H; Murata S; Kobayashi H; Inoue K; Tani T
Gastric Cancer; 2014 Oct; 17(4):630-7. PubMed ID: 24318670
[TBL] [Abstract][Full Text] [Related]
20. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
